Dark Horse is well connected within the global biotech ecosystem and enjoys making client connections for business development, investing, corporate partnerships and identification of human capital. We are headquartered in the San Francisco Bay area.
Dr Anthony Davies is the CEO of Dark Horse Consulting. He is responsible for business development, liaison with key clients and the day to day global operations of the practice. He also is a Non-Executive Director of TrakCel Ltd and sits on the Scientific Advisory Boards of several other companies in the field of cell & gene therapy. Prior to founding Dark Horse in 2014, Anthony has served as a senior executive of multiple publicly traded and privately held companies and built his career over fifteen years of solving problems of process and scale for ATMPs.
Anthony holds a PhD in chemical engineering from the University of Birmingham, Bachelors and Masters degrees in biochemistry from the University of Cambridge and is a certified Six Sigma Champion.
Dr Katy Spink joined Dark Horse as a Managing Partner in January 2018. Prior to joining Dark Horse, Dr. Spink was Chief Operating Officer of Asterias Biotherapeutics from 2013 to 2018. In this role, she led the Manufacturing, Quality, Process Development, Research, Business Development, Program Management, Facilities, and Intellectual Property functions at Asterias. Dr. Spink previously served as Senior Vice President of Alliance Management and Cell Therapy Program Operations at Geron Corporation, where she was employed in roles of increasing responsibility within the R&D and Business Development groups from 2003 through 2011. Prior to joining Geron, Dr. Spink was a management consultant at McKinsey & Company, advising clients in the biotechnology, pharmaceutical, and medical device industries on matters relating to R&D strategy, business development, and marketing. Dr. Spink graduated Magna Cum Laude and Phi Beta Kappa with a B.A. in Biochemistry from Rice University, and received her Ph.D. in Cancer Biology from Stanford University.
Jerrod Denham is a Principal and Senior Consultant at Dark Horse Consulting focusing on upstream and downstream process engineering for cell and gene therapy products. Prior to Dark Horse, Jerrod spent the last 15+ years working for biotech companies developing autologous and allogeneic cell therapy products for therapeutic applications. The majority of Jerrod’s work has been focused on hands-on development and engineering of pre-clinical to mid-phase cGMP clinical manufacturing processes and products. In 2015, Jerrod joined Dark Horse Consulting where he has provided technical support for both US and international clients and utilized his specialized skills in Lean Six Sigma, formalized root cause analysis, statistical data analysis, design of experiments, technology transfer and facility design to solve problems relating to CMC of both cell and gene therapy products.
Jerrod holds a BS in Physiological Sciences from UCLA.
Dr Chad Green is a Principal and Senior Consultant at Dark Horse Consulting responsible for partnering with clients across a broad range of technologies, including autologous and allogeneic cell therapy, biologic/device combination products, gene therapy and medical device. Prior to Dark Horse, Chad served as the Senior Director of Technical Operations at Fate Therapeutics and as the Director of Product Engineering at ViaCyte, Inc., where he was responsible for design, development, verification/validation and transfer to manufacturing activities for all macroencapsulation devices, delivery systems, disposables and ancillary surgical tools for the first-in-human cell therapy combination product. Chad specializes in process development, technology transfer and cGMP manufacturing of autologous and allogeneic cell therapies with an emphasis on iPSC and hESC-derived therapies, development of biologic/device combination products, Quality by Design, regulation of cell and gene therapies, Quality Systems for cGMP manufacturing, risk analysis and risk modeling, design control and development of Class II and III medical devices. He is an inventor on over 25 issued patents, and is a Lean Six Sigma Black Belt.
Chad holds B.S. degrees in Biochemistry and Microbiology (California Polytechnic State University, San Luis Obispo), an M.S. in Engineering, biochemical specialization (California Polytechnic State University, San Luis Obispo), a Ph.D. in Biomedical Engineering (University of California, Davis) and completed postdoctoral training at the University of California, San Diego in the Department of Pathology.
Sara Mills is a Consultant at Dark Horse Consulting focusing on process engineering, along with logistical and project management for cell and gene therapy companies and academic groups. Sara has spent over eight years working with and for academic and biotech companies focusing on applications of human primary cell cultures and autologous and allogeneic cell therapy products for therapeutic applications. Sara joined Dark Horse Consulting in 2016 where her key contributions have included JMP statistical analysis and design of experiments for multiple clients both in the US and internationally, international technology transfer of a cell therapy processes, hands-on support of key pre-clinical studies at a contract research organization and a significant amount of regulatory and clinical process-related technical writing.
Sara holds a B. Sc. In Cellular Molecular Biology from Humboldt State University in Arcata, California.
Andrew Steinsapir is a Consultant at Dark Horse Consulting. Andrew has over 5 years of gene therapy experience, leading efforts in upstream, downstream, and analytical process development. Andrew has focused on techno-economic process modeling, design of experiments, root cause analysis, and technology transfer.
Andrew holds a Lean Six Sigma Green Belt and a B.Sc. in Chemical Engineering from the University of California, Berkeley.
Christine Bui is an Associate Consultant at Dark Horse Consulting. Christine has over 10 years of operational experience in manufacturing and quality. Christine currently leads a phase-appropriate implementation of a quality system to support commercialization of Portola Pharmaceutical’s first drug. Prior to working in quality, Christine performed technical transfers and provided oversight of CMOs. Previously, Christine held positions within manufacturing and compliance at Boehringer Ingelheim and Amgen, where she gained biologics experience at a large 12kL bioreactor scale. Christine’s career started in cell therapy development and manufacturing at Geron where she developed procedures and tools to standardize the process.
Christine holds a B.Sc. in Biological Systems Engineering from UC Davis and an MBA from Santa Clara University.
Vince So is an Associate Consultant at Dark Horse Consulting. Vince has worked for various biotech companies throughout the product lifecycle, from initial concept, development, manufacturing, and sustaining stages. Vince has been able to work on products as varied as medical devices (cell therapy, laboratory consumables, surgical tools, and microfluidics), laboratory instruments, and manufacturing fixtures/equipment for process optimization. As a result, Vince has a skillset that includes engineering design, executing verification/validation protocols, authoring regulatory/planning/requirements documentation, developing manufacturing methods, and process optimization.
Vince holds a BSc and MSc in Mechanical Engineering from UCSD.
Felicity Martin is the Senior Director of Finance & Customer Relations at Dark Horse Consulting, responsible for all Finance functions, contract negotiations and customer relationship management. Prior to Dark Horse, Felicity spent 14 years at Coca-Cola Amatil., where she was responsible for leading finance teams across a broad spectrum of functions including Business Planning, Sales and Customer Service, Supply Chain and Finance Shared Services. In these roles, Felicity served as the Finance lead on functional Management teams, providing commercial decision support, leading the budgeting and forecasting process and providing analysis and insight on financials and KPIs. Prior to this, Felicity spent 2 years in Chartered Accounting.
Felicity holds a Bachelor of Commerce in Finance and Accounting (University of New South Wales, Australia) and is a CPA.
Carolyn Beck is the Executive Assistant to the CEO at Dark Horse Consulting. Providing executive support to Dr Davies, Carolyn is responsible for a broad range of administrative tasks, including calendar management, travel bookings and expense reporting. Prior to Dark Horse, Carolyn held various Executive Assistant roles at a range of companies in various industries including software, retail and health services.